SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-052074
Filing Date
2024-05-02
Accepted
2024-05-02 16:05:39
Documents
49
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gern-20240331.htm   iXBRL 10-Q 1889057
2 EX-31.1 gern-ex31_1.htm EX-31.1 15049
3 EX-31.2 gern-ex31_2.htm EX-31.2 15078
4 EX-32.1 gern-ex32_1.htm EX-32.1 8167
5 EX-32.2 gern-ex32_2.htm EX-32.2 8041
  Complete submission text file 0000950170-24-052074.txt   7512676

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT gern-20240331.xsd EX-101.SCH 1036062
53 EXTRACTED XBRL INSTANCE DOCUMENT gern-20240331_htm.xml XML 1412312
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 24908123
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)